Industry Insights – Pharmaceutical Technology talks to Qinecsa Solutions‘ CEO, Adam Sherlock about the outlook for the Life Sciences industry in 2025, focusing in on an increased scrutiny of the cost of health globally, the mega trend of AI and the potential implication for a much broader range of conditions, diseases, and treatment areas using GLP.
Watch the video interview here: Industry Outlook 2025: Through the Lens of a Service Provider
